Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Petros Pharmaceuticals Inc (PTPI)

Petros Pharmaceuticals Inc (PTPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,164
  • Shares Outstanding, K 20,685
  • Annual Sales, $ 9,560 K
  • Annual Income, $ -20,590 K
  • 60-Month Beta 1.64
  • Price/Sales 1.44
  • Price/Cash Flow N/A
  • Price/Book 1.00
Trade PTPI with:

Options Overview Details

View History
  • Implied Volatility 138.67% ( -32.30%)
  • Historical Volatility 179.87%
  • IV Percentile 77%
  • IV Rank 0.00%
  • IV High 409.30% on 12/27/21
  • IV Low 138.67% on 01/26/22
  • Put/Call Vol Ratio 0.08
  • Today's Volume 152
  • Volume Avg (30-Day) 808
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 0

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3200 +28.79%
on 01/24/22
4.0900 -58.44%
on 12/27/21
-1.7700 (-51.01%)
since 12/23/21
3-Month
1.1900 +42.86%
on 11/22/21
5.2000 -67.31%
on 11/29/21
-0.2100 (-10.99%)
since 10/26/21
52-Week
1.1900 +42.86%
on 11/22/21
5.2000 -67.31%
on 11/29/21
-2.2500 (-56.96%)
since 01/26/21

Most Recent Stories

More News
Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand...

AZ.TO : 6.19 (unch)
AAZZF : 10.8545 (+0.13%)
ACST : 1.1500 (-3.36%)
ATNM : 5.37 (-2.72%)
ADCO.TO : 0.62 (+3.33%)
ADCOF : 0.4770 (-0.71%)
ALIM : 4.30 (-1.42%)
ACOGF : 0.7890 (+7.63%)
AMST : 0.8030 (-8.00%)
ANVS : 14.27 (+1.78%)
ANPC : 0.8396 (-1.32%)
ARC : 3.36 (-3.17%)
Petros Pharmaceuticals to Participate at Upcoming Benzinga Conference and Interview Show

/PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief...

PTPI : 1.7000 (-6.08%)
Petros Pharmaceuticals Announces Closing of $5.7 Million Registered Direct Offering

/PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced the closing of its previously...

PTPI : 1.7000 (-6.08%)
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be...

XXII : 2.17 (+2.36%)
ACOG.VN : 1.000 (+1.01%)
AYRO : 1.1400 (-4.20%)
BCDA : 1.5700 (-1.26%)
BLGO : 0.2677 (+0.26%)
BITF : 3.49 (-0.29%)
BITF.VN : 4.460 (+0.68%)
BAMM.CN : 0.305 (+1.67%)
BMMJ : 0.2491 (-0.36%)
BCTX : 6.07 (-3.04%)
BCTXW : 3.07 (+2.33%)
BCT.VN : 10.600 (-3.81%)
Petros Pharmaceuticals to Participate in NobleCon17

NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals (Nasdaq: PTPI) today announces that its president and chief commercial officer Fady Boctor will present at NobleCon17 - Noble Capital...

PTPI : 1.7000 (-6.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Petros Pharmaceuticals Inc. is a men's health company. It engages in identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use...

See More

Key Turning Points

3rd Resistance Point 2.0932
2nd Resistance Point 2.0065
1st Resistance Point 1.8533
Last Price 1.7000
1st Support Level 1.6134
2nd Support Level 1.5267
3rd Support Level 1.3735

See More

52-Week High 5.2000
Fibonacci 61.8% 3.6682
Fibonacci 50% 3.1950
Fibonacci 38.2% 2.7218
Last Price 1.7000
52-Week Low 1.1900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar